Načítá se...
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
<p>Abstract</p> <p>Background</p> <p>The <it>enhancer of zeste homolog 2 </it>(<it>EZH2</it>) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association bet...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2010-10-01
|
| Edice: | BMC Cancer |
| On-line přístup: | http://www.biomedcentral.com/1471-2407/10/524 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|